CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial

Press/Media

Period	1 Apr 2021

Media coverage

Title	CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
Media name/outlet	Nasdaq
Country/Territory	United States
Date	1/04/21
URL	https://www.nasdaq.com/press-release/cti-biopharma-announces-enrollment-of-first-patient-in-covid-19-pre-vent-phase-3
Persons	John Mascarenhas